Connor, Clark & Lunn Investment Management (CC&L)’s Novavax NVAX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-44,260
| Closed | -$559K | – | 1565 |
|
|
2024
Q3 | $559K | Sell |
44,260
-97,515
| -69% | -$1.23M | ﹤0.01% | 1072 |
|
|
2024
Q2 | $1.79M | Buy |
+141,775
| New | +$1.79M | 0.01% | 684 |
|
|
2022
Q2 | – | Sell |
-259,383
| Closed | -$19.1M | – | 1157 |
|
|
2022
Q1 | $19.1M | Buy |
259,383
+75,823
| +41% | +$5.58M | 0.09% | 160 |
|
|
2021
Q4 | $26.3M | Sell |
183,560
-1,206
| -0.7% | -$173K | 0.13% | 137 |
|
|
2021
Q3 | $38.3M | Buy |
184,766
+117,238
| +174% | +$24.3M | 0.2% | 99 |
|
|
2021
Q2 | $14.3M | Buy |
67,528
+31,931
| +90% | +$6.78M | 0.07% | 198 |
|
|
2021
Q1 | $6.45M | Sell |
35,597
-26,493
| -43% | -$4.8M | 0.04% | 306 |
|
|
2020
Q4 | $6.92M | Sell |
62,090
-3,952
| -6% | -$441K | 0.04% | 272 |
|
|
2020
Q3 | $7.16M | Buy |
66,042
+21,498
| +48% | +$2.33M | 0.05% | 246 |
|
|
2020
Q2 | $3.71M | Buy |
+44,544
| New | +$3.71M | 0.03% | 351 |
|
|
2018
Q4 | – | Sell |
-155,553
| Closed | -$292K | – | 1017 |
|
|
2018
Q3 | $292K | Buy |
155,553
+114,253
| +277% | +$214K | ﹤0.01% | 790 |
|
|
2018
Q2 | $55K | Buy |
+41,300
| New | +$55K | ﹤0.01% | 1011 |
|
|
2015
Q2 | – | Sell |
-80,900
| Closed | -$669K | – | 650 |
|
|
2015
Q1 | $669K | Buy |
80,900
+39,600
| +96% | +$327K | 0.01% | 361 |
|
|
2014
Q4 | $245K | Buy |
+41,300
| New | +$245K | ﹤0.01% | 498 |
|
|
2014
Q2 | – | Sell |
-328,835
| Closed | -$1.64M | – | 605 |
|
|
2014
Q1 | $1.64M | Buy |
+328,835
| New | +$1.64M | 0.01% | 300 |
|